SOTK News & Events

Reports Q3 revenue $5M vs $5.1M last year. Dr. Christopher Coccio, Executive Chairman, stated, "We delivered another solid quarter marked by our seventh consecutive period of revenue above $5 million, continued profitability, and meaningful margin expansion. The improvement in gross margin reflects the success of our strategy to prioritize higher-ASP production systems and maintain disciplined cost management, even as certain end markets experience near-term variability. Reaching a record backlog is particularly encouraging and highlights sustained customer confidence in Sono-Tek's technology and long-term value proposition."

Reports Q2 revenue $5.163M vs $5.162M last year. Dr. Christopher Coccio, Executive Chairman, stated, "We are pleased to report continued growth and profitability in line with our guidance with the continuing trend of over $5 million in quarterly revenue for the past six quarters. Importantly, we remain solidly profitable with strong margins and effective cost controls. Based on projected shipments for the second half of our fiscal year 2026, we are raising guidance slightly, now anticipating modest revenue growth, taking into consideration evolving governmental clean energy incentives and tariff policies which each may affect the initiation and timing of customer orders. Despite the evolving landscape in the clean energy industry, we have successfully offset it with our diversification strategy into other sectors such as the medical device industry. It is gratifying to see the promising demand in the medical device industry that we projected coming to fruition with our recently announced $5 million dollar order for multiple state-of-the-art MediCoat systems designed for high-precision, scalable manufacturing in addition to our most recent order of over $2.8 million from another major medical device manufacturer. With a healthy balance sheet, solid backlog and strong customer demand, we remain laser focused on execution and look forward to building on our recent success."

Sono-Tek announced that it has received a purchase order valued at over $2.8M from a major U.S.based medical device manufacturer. This order, placed by an existing customer which is ramping up production, includes multiple advanced ExactaCoat MD systems. The ExactaCoat MD systems include expanded capabilities compared to Sono-Tek's previously supplied equipment. These new systems will be installed in addition to the customer's existing Sono-Tek coating equipment, which will remain in production use. Deliveries of the new equipment are expected to begin in the beginning of calendar year 2026 and be completed within the first half of 2026.

Sono-Tek announced that it has received a multi-million dollar purchase order, valued at over $5 million, for coating systems to be used in the production of a medical device. The order includes multiple state-of-the-art MediCoat systems designed for high-precision, scalable manufacturing. Deliveries under this order are expected to commence in calendar year 2026 and will be completed over approximately a 12-month period. Steve Harshbarger, President and CEO of Sono-Tek, commented: "This order reflects the growing adoption of Sono-Tek's advanced coating platforms by leading medical device manufacturers worldwide. It is also a strong validation of our strategy - focusing on complex, high-value production systems with higher average selling prices and expanding our reach across multiple high-growth markets. We are proud to support our customers as they scale up production of innovative healthcare technologies."